PH31439A - Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol. - Google Patents

Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol.

Info

Publication number
PH31439A
PH31439A PH49098A PH49098A PH31439A PH 31439 A PH31439 A PH 31439A PH 49098 A PH49098 A PH 49098A PH 49098 A PH49098 A PH 49098A PH 31439 A PH31439 A PH 31439A
Authority
PH
Philippines
Prior art keywords
cholecalciferol
ene
dihydroxy
stable
active metabolites
Prior art date
Application number
PH49098A
Other languages
English (en)
Inventor
Mclane John Arthur
Satyanarayama G Reddy
Milar R Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH31439A publication Critical patent/PH31439A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH49098A 1993-10-01 1994-09-30 Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol. PH31439A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/131,264 US5401733A (en) 1993-10-01 1993-10-01 Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol

Publications (1)

Publication Number Publication Date
PH31439A true PH31439A (en) 1998-11-03

Family

ID=22448675

Family Applications (1)

Application Number Title Priority Date Filing Date
PH49098A PH31439A (en) 1993-10-01 1994-09-30 Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol.

Country Status (15)

Country Link
US (1) US5401733A (da)
EP (1) EP0646576B1 (da)
JP (1) JP2677520B2 (da)
CN (1) CN1041201C (da)
AT (1) ATE162786T1 (da)
AU (1) AU683917B2 (da)
CA (1) CA2133144C (da)
DE (1) DE69408244T2 (da)
DK (1) DK0646576T3 (da)
ES (1) ES2113020T3 (da)
GR (1) GR3026154T3 (da)
NZ (1) NZ264537A (da)
PH (1) PH31439A (da)
RU (1) RU2133738C1 (da)
ZA (1) ZA947453B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9524812D0 (en) * 1995-12-05 1996-02-07 Leo Pharm Prod Ltd Chemical compounds
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
KR20050123185A (ko) * 1996-12-20 2005-12-29 쥬가이 세이야쿠 가부시키가이샤 16-엔-비타민 d 유도체
JPH10316652A (ja) * 1997-05-02 1998-12-02 Duphar Internatl Res Bv 16−デヒドロビタミンd化合物の製造方法
CA2289209C (en) 1997-05-16 2006-07-25 Women & Infants Hospital Cyclic ether vitamin d3 compounds, 1.alpha. (oh) 3-epi-vitamin d3 compounds and uses thereof
DE69834109T2 (de) * 1997-05-16 2007-04-19 Woman & Infants Hospital 3-epi-vitamin d2 verbindungen und ihre anwendungen
WO1999011272A1 (en) * 1997-09-02 1999-03-11 Johns Hopkins University School Of Medicine Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
JP2004292314A (ja) * 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd ケラチノサイト増殖抑制剤

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617297A (en) * 1982-02-12 1986-10-14 Hoffmann-La Roche Inc. Method of treating disease states by the administration of 1α,25,26-trihydroxycholecalciferol
US4594432A (en) * 1983-01-28 1986-06-10 Hoffman-La Roche Inc. Process for the synthesis of 1α,23(S),25-trihydroxycholecalciferol and 1α,23(R),25-trihydroxycholecalciferol
US4501738A (en) * 1983-06-30 1985-02-26 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient to treat pain, pyrexia or inflammatory diseases
US4495181A (en) * 1983-10-03 1985-01-22 The Regents Of The University Of California 1,25-Dihydroxy-24-oxo-vitamin D3 and 1,23,25-trihydroxy-24-oxo-vitamin D3
US4719205A (en) * 1984-01-30 1988-01-12 Wisconsin Alumini Research Foundation Side-chain unsaturated 1-hydroxyvitamin D compounds
JPS6144860A (ja) * 1984-08-10 1986-03-04 Taisho Pharmaceut Co Ltd 1α.25−ジヒドロキシ−26.27−ジメチルビタミンD↓3
JPS61129130A (ja) * 1984-11-27 1986-06-17 Kureha Chem Ind Co Ltd 抗尿毒症剤
US4612308A (en) * 1984-11-29 1986-09-16 Hoffmann-La Roche Inc. 25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers
ATE45347T1 (de) * 1985-05-30 1989-08-15 Taisho Pharmaceutical Co Ltd Vitamin d3-derivate.
WO1987003282A1 (fr) * 1985-11-21 1987-06-04 Taisho Pharmaceutical Co., Ltd. Derive de la vitamine d3
JPS6391323A (ja) * 1986-10-03 1988-04-22 Kureha Chem Ind Co Ltd 抗尿路結石症剤
US5001118A (en) * 1986-12-29 1991-03-19 Kureha Kagaku Kogyo Kabushiki Kaisha Method for preventing senescence and increasing bone mass
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4851401A (en) * 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
DE4011682A1 (de) * 1990-04-06 1991-10-10 Schering Ag 24-oxa-derivate in der vitamin d-reihe
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives

Also Published As

Publication number Publication date
RU94035663A (ru) 1996-07-20
JP2677520B2 (ja) 1997-11-17
ES2113020T3 (es) 1998-04-16
DE69408244D1 (de) 1998-03-05
EP0646576A1 (en) 1995-04-05
NZ264537A (en) 1996-05-28
CN1106384A (zh) 1995-08-09
CN1041201C (zh) 1998-12-16
CA2133144C (en) 2005-05-24
CA2133144A1 (en) 1995-04-02
ATE162786T1 (de) 1998-02-15
DK0646576T3 (da) 1998-09-23
EP0646576B1 (en) 1998-01-28
JPH07179418A (ja) 1995-07-18
AU683917B2 (en) 1997-11-27
RU2133738C1 (ru) 1999-07-27
US5401733A (en) 1995-03-28
AU7422594A (en) 1995-04-13
GR3026154T3 (en) 1998-05-29
DE69408244T2 (de) 1998-08-27
ZA947453B (en) 1995-04-03

Similar Documents

Publication Publication Date Title
DE122006000018I2 (de) 19-Nor-Vitamin-D-Derivate.
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
SG52320A1 (en) Novel (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
PH24969A (en) Insecticidal pyrazolines
PH31439A (en) Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol.
DE60018554D1 (de) Arzneimittel zur förderung der neuronalen zelldifferenzierung, die cyclische glycerophosphate und deren analoga enthalten
ZA955826B (en) Dinucleoside-5',5'pyrophosphates
BG101126A (en) The use of muramylpeptide compounds
BG103260A (en) The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
ES8302634A1 (es) Procedimiento de preparacion de derivados del acido metilen-2-succinamico
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
IL57609A (en) Pharmaceutical compositions for the treatment of sickle cell disease comprising p-nitrobenzyl esters or amides of aromatic or hydrophobic aminoacids
EP0551844A3 (da)
HK64993A (en) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
IE830308L (en) Selective herbicidals
IT1244459B (it) Composizione terapeutica per il trattamento di malattie della pelle quali vitiligine,acne,psoriasi,alopecia,ipotricosi
GR3024709T3 (en) Novel cytarabine derivatives, their production and use
RU95100512A (ru) Мазь для лечения кожных заболеваний